BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
Boehm D, Calvanese V, Dar RD, Xing S, Schroeder S, Martins L, Aull K, Li PC, Planelles V, Bradner JE, Zhou MM, Siliciano RF, Weinberger L, Verdin E, Ott M.
Boehm D, et al. Among authors: dar rd.
Cell Cycle. 2013 Feb 1;12(3):452-62. doi: 10.4161/cc.23309. Epub 2012 Feb 1.
Cell Cycle. 2013.
PMID: 23255218
Free PMC article.